Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review.

Abstract

The inflammatory process plays a central role in the development and progression of numerous pathological situations, such as inflammatory bowel disease (IBD), autoimmune and neurodegenerative diseases, metabolic syndrome, and cardiovascular disorders. IBDs involve inflammation of the gastrointestinal area and mainly comprise Crohn's disease (CD) and ulcerative colitis (UC). Both pathological situations usually involve recurring or bloody diarrhea, pain, fatigue and weight loss. There is at present no pharmacological cure for CD or UC. However, surgery may be curative for UC patients. The prescribed treatment aims to ameliorate the symptoms and prevent and/or delay new painful episodes. Flavonoid compounds are a large family of hydroxylated polyphenolic molecules abundant in plants, including vegetables and fruits which are the major dietary sources of these compounds for humans, together with wine and tea. Flavonoids are becoming very popular because they have many health-promoting and disease-preventive effects. Most interest has been directed towards the antioxidant activity of flavonoids, evidencing a remarkable free-radical scavenging capacity. However, accumulating evidence suggests that flavonoids have many other biological properties, including anti-inflammatory, antiviral, anticancer, and neuroprotective activities through different mechanisms of action. The present review analyzes the available data about the different types of flavonoids and their potential effectiveness as adjuvant therapy of IBDs.

• Authors: Ali Salaritabar, Behrad Darvishi, Farzaneh Hadjiakhoondi, Azadeh Manayi, Antoni Sureda, Seyed Fazel Nabavi, Leo R Fitzpatrick, Seyed Mohammad Nabavi, Anupam Bishayee
• Journal: World journal of gastroenterology (World J Gastroenterol) Vol. 23 Issue 28 Pg. 5097-5114 (Jul 28 2017) ISSN: 2219-2840 [Electronic] United States
• PMID: 28811706 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Inflammatory Agents
• Flavonoids

Topics

• Animals
• Anti-Inflammatory Agents (therapeutic use)
• Clinical Trials as Topic
• Colitis, Ulcerative (drug therapy, pathology)
• Colon (drug effects, pathology)
• Crohn Disease (drug therapy, pathology)
• Disease Models, Animal
• Flavonoids (pharmacology, therapeutic use)
• Intestinal Mucosa (drug effects, pathology)
• Treatment Outcome